07.12.2010 • News

Uta Kemmerich-Keil: Merck KGaA to Refrain From Big Deals For Now

Uta Kemmerich-Keil is the head of Mercks corporate finance
Uta Kemmerich-Keil is the head of Merck's corporate finance

German drugmaker Merck KGaA will take a breather from pursuing larger takeover deals as it integrates its latest acquisition Millipore, a company executive said on Tuesday.

"You will not see us involved in transactions of (Millipore's) size in the short term," the company's head of corporate finance, Uta Kemmerich-Keil, said at an event, adding that management's focus was on integrating the laboratory equipment supplier.

Merck agreed to buy U.S. biotech tool maker Millipore for $6 billion in cash in February to diversify away from its pharmaceuticals business.

Company

Logo:

Merck KGaA

Frankfurter Str. 250
64293 Darmstadt
Germany

Company contact







Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.